2025 Annual Meeting | Neuroimmunology & Neuroinflammation 2015-2025: A View from 30,000 Feet
Program Materials Program Evaluations
| 03:00 PM - 04:00 PM PDT | Speaker |
Neuroimmunology & Neuroinflammation 2015-2025: A View from 30,000 Feet
Jose G. Merino, MD, MPhil, FAHA, FAAN, Richard M. Ransohoff, MD, Scott S. Zamvil, MD, PhD, FAAN, Josep O. Dalmau, MD, PhD, FAAN |
| Jose G. Merino, MD, MPhil, FAHA, FAAN | The institution of Dr. Merino has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Merino has received personal compensation in the range of $500-$4,999 for serving as a StrokeNet DSMB Member with National Institute of Neurological Disorders and Stroke. |
| Richard M. Ransohoff, MD | Dr. Ransohoff has received personal compensation for serving as an employee of Third Rock Ventures. Dr. Ransohoff has stock in Biogen. Dr. Ransohoff has received intellectual property interests from a discovery or technology relating to health care. |
| Scott S. Zamvil, MD, PhD, FAAN | Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Zamvil has received research support from Sumaira Foundation. Dr. Zamvil has received personal compensation in the range of $5,000-$9,999 for serving as a Advisory Board with Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Genentech. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Alexion. |
| Josep O. Dalmau, MD, PhD, FAAN | Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. |